Literature DB >> 29699169

Delivery of a healthy newborn using vitrified zygotes that developed from in vitro matured oocytes retrieved from a patient with polycystic ovarian syndrome.

Hiroaki Yoshida1, Nobuya Aono1, Yasuhisa Araki2, Takako Naganuma3.   

Abstract

The aim of this study is to evaluate vitrified zygotes, which were developed from in vitro matured oocytes that were retrieved from a patient with polycystic ovarian syndrome. Oocyte retrieval was performed on day 15 following withdrawal bleeding. The oocytes were incubated for 24 h in human tissue culture medium (TCM)-199 maturation medium supplemented with 20% filtrated-mixed patients follicle fluid, follicle stimulating hormone (FSH), and human chorionic gonadotropin (hCG). A total of four immature oocytes were collected. Two of the four oocytes (50.0%) developed to the metaphase-II stage and, subsequently, two fertilized oocytes were vitrified at the pronuclear stage because a very thin endometrium was not conducive for transfer. One of the two vitrified zygotes was thawed and developed to a 4-cell cleavage stage embryo within 24 h. Subsequent to the embryo transfer, a healthy newborn was delivered. A successful delivery was ensued by using vitrified zygotes from an anovulatory woman with polycystic ovarian syndrome. (Reprod Med Biol 2003; 2: 87-90).

Entities:  

Keywords:  intracytoplasmic sperm injection; mature oocyte; polycystic ovarian syndrome; vitrification

Year:  2003        PMID: 29699169      PMCID: PMC5907110          DOI: 10.1046/j.1445-5781.2003.00025.x

Source DB:  PubMed          Journal:  Reprod Med Biol        ISSN: 1445-5781


  13 in total

1.  Morphology of in-vitro matured oocytes: impact on fertility potential and embryo quality.

Authors:  A L Mikkelsen; S Lindenberg
Journal:  Hum Reprod       Date:  2001-08       Impact factor: 6.918

2.  Successful delivery following cryopreservation of zygotes produced by in vitro matured oocytes retrieved from a woman with polycystic ovarian syndrome-like disease: a case report.

Authors:  Koichi Kyono; Noritaka Fukunaga; Kosuke Haigo; Setsuyo Chiba; Chisako Ohira; Yukiko Nakajo; Yasuhisa Araki
Journal:  J Assist Reprod Genet       Date:  2002-08       Impact factor: 3.412

3.  Blastocyst development and pregnancies after IVF of mature oocytes retrieved from unstimulated patients with PCOS after in-vivo HCG priming.

Authors:  Weon-Young Son; San-Hyun Yoon; Suk-Won Lee; Yong Ko; Hye-Gyun Yoon; Jin-Ho Lim
Journal:  Hum Reprod       Date:  2002-01       Impact factor: 6.918

4.  Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome.

Authors:  R C Chian; W M Buckett; T Tulandi; S L Tan
Journal:  Hum Reprod       Date:  2000-01       Impact factor: 6.918

5.  Pregnancy and delivery after cryopreservation of zygotes produced by in-vitro matured oocytes retrieved from a woman with polycystic ovarian syndrome.

Authors:  R C Chian; B Gülekli; W M Buckett; S L Tan
Journal:  Hum Reprod       Date:  2001-08       Impact factor: 6.918

6.  Embryo cryopreservation at the pronuclear stage and efficient embryo use optimizes the chance for a liveborn infant from a single oocyte retrieval.

Authors:  M A Damario; D G Hammitt; D R Session; D A Dumesic
Journal:  Fertil Steril       Date:  2000-04       Impact factor: 7.329

7.  Prospective randomized study of two cryopreservation policies avoiding embryo selection: the pronucleate stage leads to a higher cumulative delivery rate than the early cleavage stage.

Authors:  A Senn; C Vozzi; A Chanson; P De Grandi; M Germond
Journal:  Fertil Steril       Date:  2000-11       Impact factor: 7.329

8.  Functional integrity of granulosa cells from polycystic ovaries.

Authors:  G Almahbobi; C Anderiesz; P Hutchinson; J R McFarlane; C Wood; A O Trounson
Journal:  Clin Endocrinol (Oxf)       Date:  1996-05       Impact factor: 3.478

Review 9.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors:  A Dunaif
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

Review 10.  Maturation in vitro of immature human oocytes for clinical use.

Authors:  K Y Cha; R C Chian
Journal:  Hum Reprod Update       Date:  1998 Mar-Apr       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.